Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Interventional × Proteus Syndrome × Miransertib × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 2 Expanded_access 1

Sponsor

Conditions

Proteus Syndrome 2 Neoplasms 1 Lymphoma 1 Endometrial Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04316546 2026-03-11

MK-7075 (Miransertib) in Proteus Syndrome

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting

Proteus Syndrome

NCT02594215 2022-06-30

Dose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome

National Institutes of Health Clinical Center (CC)

Phase 1 Completed

Proteus Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡